A prodrug form of quinaprilat
Related Products
Active Metabolite(s)
36007Quinaprilat
Labeled Version(s)
30735Quinapril-d5
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Quinapril (hydrochloride)

Item No. 21439

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, monohydrochloride
CAS Number
82586-55-8
Synonyms
  • CI-906
  • PD 109452-2
Molecular Formula
C25H30N2O5 • HCl
Formula Weight
475.0
Purity
≥98%
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 30 mg/mlDMSO: 30 mg/mlEthanol: 30 mg/mlPBS (pH 7.2): 3.33 mg/ml
SMILES
O=C(OCC)[C@@H](N[C@@H](C)C(N1[C@H](C(O)=O)CC(C=CC=C2)=C2C1)=O)CCC3=CC=CC=C3.Cl
InChi Code
InChI=1S/C25H30N2O5.ClH/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30;/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30);1H/t17-,21-,22-;/m0./s1
InChi Key
IBBLRJGOOANPTQ-JKVLGAQCSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    250 mg

    $129

    Add

    500 mg

    $218

    Add

    1 g

    $306

    Add

    5 g

    $864

    Add
    Product Description

    Quinapril is a prodrug form of the angiotensin converting enzyme (ACE) inhibitor quinaprilat.1,2 In vivo, quinapril (3 mg/kg) reduces mean arterial pressure in renal hypertensive and spontaneously hypertensive rats.2 It inhibits angiotensin I-induced pressor responses in normotensive rats and dogs. Quinapril (10-200 mg/kg) prevents left ventricular heart failure in CHF 14.6 cardiomyopathic hamsters. Formulations containing quinapril have been used in the treatment of hypertension, heart failure, and diabetic nephropathy.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Vago, T., Bevilacqua, M., Conci, F., et al. Angiotensin converting enzyme binding sites in human heart and lung: Comparison with rat tissues. Br. J. Pharmacol. 107(3), 821-825 (1992).

    2. Kaplan, H.R., Taylor, D.G., and Olson, S.C. Quinapril: Overview of preclinical data. Clin. Cardiol. 13(6 Suppl. 7), VII6-VII12 (1990).